Holen Sie sich die Stockscreener-App
0.3696
3.97%
0.0141
Io Biotech Inc Aktie (IOBT) Neueste Nachrichten
Will IO Biotech Inc. outperform its industry peers2025 Technical Overview & Free Real-Time Volume Trigger Notifications - mfd.ru
IO Biotech Faces Nasdaq Noncompliance, Potential Delisting Risk - TipRanks
IO Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns IO Biotech (NASDAQ: IOBT) on $50M market value rule - Stock Titan
Here's Why IO Biotech, Inc. (IOBT) Looks Ripe for Bottom Fishing - Finviz
Is IO Biotech Inc. a top pick in the sectorJuly 2025 Catalysts & Short-Term High Return Ideas - mfd.ru
Layoff Tracker: Delayed Notice Reveals 141 More Layoffs From Genentech in 2025 - BioSpace
Guidance Update: Is IO Biotech Inc in a consolidation phaseJuly 2025 PostEarnings & Safe Capital Growth Tips - baoquankhu1.vn
Fierce Biotech Layoff Tracker 2026: ARPA-H makes cuts; GSK trims R&D team - Fierce Biotech
IO Biotech Provides Corporate Update - marketscreener.com
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IO Biotech (IOBT) launches restructuring, CMO exit and up to $2.6M charges - Stock Titan
IO Biotech hires Raymond James as advisor, cuts workforce By Investing.com - Investing.com Canada
IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction and Cost-Containment Measures - Quiver Quantitative
Cancer vaccine maker IO Biotech cuts staff, hires Raymond James - Stock Titan
Piper downgrades IO Biotech amid strategic alternatives evaluation - Yahoo Finance
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review By Investing.com - Investing.com South Africa
IO Biotech stock tumbles after Piper Sandler downgrades on strategic review - Investing.com South Africa
Piper Sandler Downgrades IO Biotech (IOBT) to Neutral, Lowers Pr - GuruFocus
Piper Sandler Downgrades IO Biotech to Neutral From Overweight, Adjusts Price Target to $0.50 From $3 - marketscreener.com
IO Biotech stock rating downgraded by Piper Sandler amid strategic review - Investing.com South Africa
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - MSN
Aug Decliners: Is IO Biotech Inc a potential multi baggerMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
IOBT IO Biotech, Inc. (NASDAQ) $0.47 on 22 Jan 2026: active intraday mover for traders - Meyka
IO Biotech’s Future Uncertain As Cylembio Cloud Remains - Citeline News & Insights
IO Biotech Begins Review Of Strategic Options As Cash Runway Narrows - Nasdaq
IO Biotech weighs strategic options months after FDA advises against melanoma vaccine filing - European Biotechnology Magazine
IO Biotech admits defeat | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Listed Danish biotech company fights for survival after FDA rejection and failed capital raising - medwatch.com
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
IO Biotech stock plummets after company explores strategic alternatives By Investing.com - Investing.com Nigeria
IO Biotech stock plummets after company explores strategic alternatives - Investing.com
IO Biotech announces exploration of strategic alternatives - TipRanks
IO mulls more layoffs months after halving head count in wake of cancer vaccine setback - Fierce Biotech
IO Biotech Explores Strategic Alternatives Amid Cost-Cutting Plans - TipRanks
IO Biotech (IOBT) Explores Strategic Alternatives to Maximize Shareholder Value - Intellectia AI
IO Biotech, Inc. Announces Exploration of Strategic Alternatives - TradingView
IO Biotech to explore strategic alternatives - MSN
IO Biotech Announces Exploration of Strategic Alternatives - The Manila Times
IO Biotech Announces Exploration of Strategic Alternatives to Enhance Stockholder Value - Quiver Quantitative
Moderna cancer vaccine holds up; IO Biotech considers a sale - Yahoo Finance
Cancer vaccine developer weighs sale, merger or liquidation - Stock Titan
IO Biotech explores strategic alternatives to maximize shareholder value - Intellectia AI
Merger Talk: Does IO Biotech Inc align with a passive investing strategy2025 Technical Patterns & Verified Swing Trading Watchlist - baoquankhu1.vn
Market Review: How do insiders feel about SOPAWeekly Stock Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
Market Trends: What is the long term forecast for IO Biotech Inc stockJuly 2025 Momentum & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Valuation Update: Can ALCY lead its sector in growthWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
Jefferies maintains IO Biotech Buy rating, $8 target on PFS hopes - MSN
IO Biotech Faces Existential Threats as Funding and Regulatory Woes Mount - AD HOC NEWS
Aug Shorts: Will IO Biotech Inc outperform tech stocksJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
What margin trends mean for IO Biotech Inc. stockMarket Growth Report & Weekly Setup with High ROI Potential - Bộ Nội Vụ
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):